Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | CMA1 | P23946 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | MIF | P14174 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11874168 | 0.83 | CYP3A4 (0.55) | CYP3A4SLC6A4KMT2ATDP1L3MBTL1 | |
| SCHEMBL11240060 | 0.80 | CYP3A4 (0.64) | CYP3A4SLC6A4KMT2ATDP1L3MBTL1 | |
| SCHEMBL30194840 | 0.80 | CYP3A4 (0.64) | CYP3A4SLC6A4KMT2ATDP1L3MBTL1 | |
| SCHEMBL3417124 | 0.80 | CYP3A4 (0.64) | CYP3A4SLC6A4KMT2ATDP1L3MBTL1 | |
| SCHEMBL9548239 | 0.78 | CYP3A4 (0.62) | CYP3A4SLC6A4KMT2ATDP1L3MBTL1 | |
| SCHEMBL2119072 | 0.77 | TAAR1 (0.59) | CYP3A4SLC6A4KMT2ATDP1L3MBTL1 | |
| SCHEMBL1520844 | 0.77 | CYP3A4 (0.60) | CYP3A4SLC6A4KMT2ATDP1L3MBTL1 | |
| SCHEMBL8724921 | 0.77 | CYP3A4 (0.60) | CYP3A4SLC6A4KMT2ATDP1L3MBTL1 | |
| SCHEMBL2090515 | 0.77 | CYP3A4 (0.60) | CYP3A4SLC6A4KMT2ATDP1L3MBTL1 | |
| SCHEMBL10533406 | 0.77 | CYP3A4 (0.65) | CYP3A4SLC6A4TAAR1CYP1A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1501812-B1 | PNA MONOMER AND PRECURSOR | PANAGENE INC (KR) | 2009-12-30 | — | — | EP | claimed |
| EP-1651642-B1 | PNA MONOMER AND PRECURSOR | PANAGENE INC (KR) | 2009-11-04 | — | — | EP | claimed |
| US-20070161634-A1 | Compounds as CCR5 antagonists | SHANGHAI TARGET DRUG CO., LTD. (CN) | 2007-07-12 | — | — | US | claimed |
| US-7211668-B2 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2007-05-01 | — | — | US | claimed |
| EP-1760079-A1 | COMPOUNDS AS COR5 ANTAGONISTS | Shanghai Target Drug Co., Ltd. (CN) | 2007-03-07 | — | — | EP | claimed |
| US-7179896-B2 | Method of making PNA oligomers | PANAGENE, INC. (KR) | 2007-02-20 | — | — | US | claimed |
| EP-1651642-A4 | PNA MONOMER AND PRECURSOR | PANAGENE INC (KR) | 2006-11-29 | — | — | EP | claimed |
| EP-1501812-A4 | PNA MONOMER AND PRECURSOR | PANAGENE INC (KR) | 2006-05-24 | — | — | EP | claimed |
| EP-1651642-A1 | PNA MONOMER AND PRECURSOR | Panagene Inc. (KR) | 2006-05-03 | — | — | EP | claimed |
| US-20060003374-A1 | Method of making PNA oligomers | KIM SUNG K | 2006-01-05 | — | — | US | claimed |
| US-6969766-B2 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2005-11-29 | — | — | US | claimed |
| WO-2005009998-A1 | PNA MONOMER AND PRECURSOR | PANAGENE INC. (US) | 2005-02-03 | — | — | WO | claimed |
| US-20050026930-A1 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2005-02-03 | — | — | US | claimed |
| EP-1501812-A1 | PNA MONOMER AND PRECURSOR | Panagene, Inc. (KR) | 2005-02-02 | — | — | EP | claimed |
| US-20030225252-A1 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2003-12-04 | — | — | US | claimed |
| WO-2003091231-A1 | PNA MONOMER AND PRECURSOR | PANAGENE, INC. (US) | 2003-11-06 | — | — | WO | claimed |
| CN-112533695-A | Enhancing efficiency of photochemical reactions on a substrate | 生捷科技控股公司 | 2021-03-19 | — | — | CN | disclosed |
| EP-2174936-B1 | PNA monomer and precursor | PANAGENE INC (KR) | 2013-09-04 | — | — | EP | disclosed |
| US-4374129-A | Antibiotically active aminopapulacandin derivatives | CIBA-GEIGY CORPORATION (US) | 1983-02-15 | — | — | US | disclosed |
| EP-0054514-A1 | Derivatives of aminopapulacandin having antibiotic activity | CIBA-GEIGY AG (CH) | 1982-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225252-A1 | PNA monomer and precursor | PNISR, RNGTT, NCL | CYP3A4 4571/4885SLC6A4 3814/4885KMT2A 4071/4885 |
| US-20050026930-A1 | PNA monomer and precursor | RNGTT, POLL, NSUN3 | CYP3A4 4099/4885SLC6A4 2780/4885KMT2A 4464/4885 |
| US-20070161634-A1 | Compounds as CCR5 antagonists | CCR5, CXCR3, CCL5 | CYP3A4 722/4885SLC6A4 320/4885KMT2A 4577/4885 |
| US-20060003374-A1 | Method of making PNA oligomers | RNGTT, POLL, PNISR | CYP3A4 4675/4885SLC6A4 3224/4885KMT2A 4022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.